Medlive Technology Co., Ltd. (HKG:2192)

Medlive Technology Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	1,586	2,567	3,845	4,358	4,187	3,879
Short-Term Investments	723.58	961.31	205.6	5.21	4.66	4.88
Trading Asset Securities	352.34	200.34	102.15	42.64	29.64	29.64
Cash & Short-Term Investments	2,662	3,729	4,152	4,406	4,222	3,914
Cash Growth	-26.43%	-10.20%	-5.76%	4.37%	7.87%	2531.98%
Receivables	258.45	253.52	174.85	155.92	124.21	95.87
Inventory	-	-	-	0.1	0.2	0.09
Other Current Assets	16.86	8.64	29.18	10.46	5.76	3.41
Total Current Assets	2,938	3,991	4,356	4,573	4,352	4,013
Property, Plant & Equipment	25.64	32.89	38.05	11.08	14.57	16.87
Long-Term Investments	1,823	864.37	440.73	42.37	92.79	0.34
Goodwill	192.53	192.53	192.53	192.53	111.52	69.72
Other Intangible Assets	60.37	40.15	29.44	27.54	16.19	9.3
Long-Term Deferred Tax Assets	4.87	8.23	8.26	8.52	8.28	6.33
Long-Term Deferred Charges	-	27.92	42.69	39.2	8.14	-
Total Assets	5,044	5,157	5,108	4,894	4,603	4,116

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	37.07	22.28	13.86	14.77	2.71	6.22
Accrued Expenses	-	87.95	79.37	74.55	62.85	45.79
Current Portion of Leases	1.96	7.91	11.6	4.55	5.14	4.21
Current Income Taxes Payable	18.89	13.89	14.69	16.97	25.03	24.22
Current Unearned Revenue	-	43.25	49.71	43.77	12.81	7.81
Other Current Liabilities	121.52	33.82	37.87	35.16	24.21	24.97
Total Current Liabilities	179.44	209.1	207.11	189.77	132.75	113.21
Long-Term Leases	4.47	2.2	11.03	3.64	6.13	8.96
Long-Term Deferred Tax Liabilities	6.02	9.68	8.71	7.54	4.64	2.71
Other Long-Term Liabilities	-	8.92	26.72	47.66	27.8	18.49
Total Liabilities	189.93	229.91	253.57	248.61	171.32	143.37

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.05	0.05	0.05	0.05	0.05	0.04
Additional Paid-In Capital	-	3,907	3,906	3,904	3,898	3,898
Retained Earnings	-	596.96	448.18	312.07	194.46	89.27
Comprehensive Income & Other	4,799	359.07	444.9	381.6	308.13	-39.01
Total Common Equity	4,799	4,864	4,799	4,597	4,401	3,949
Minority Interest	54.37	63.57	55.59	47.83	30.89	23.49
Shareholders' Equity	4,854	4,927	4,855	4,645	4,432	3,972
Total Liabilities & Equity	5,044	5,157	5,108	4,894	4,603	4,116

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	6.43	10.11	22.63	8.19	11.26	13.17
Net Cash (Debt)	2,656	3,719	4,130	4,398	4,210	3,900
Net Cash Growth	-26.30%	-9.96%	-6.10%	4.46%	7.94%	2754.96%
Net Cash Per Share	3.61	5.05	5.61	5.99	5.72	6.13
Filing Date Shares Outstanding	738.7	737.03	732.88	726.96	717.35	713.23
Total Common Shares Outstanding	738.7	737.03	732.88	726.96	717.35	713.23
Working Capital	2,758	3,782	4,149	4,383	4,219	3,900
Book Value Per Share	6.50	6.60	6.55	6.32	6.14	5.54
Tangible Book Value	4,546	4,631	4,577	4,377	4,273	3,870
Tangible Book Value Per Share	6.15	6.28	6.25	6.02	5.96	5.43
Machinery	-	19.63	9.35	8.08	7.21	5.87
Leasehold Improvements	-	11.7	10.67	7.07	7.07	7.07

Data Source: S&P Global Market Intelligence Last updated: Aug 28, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 12, 2026

Data Sources Report a data error